Skip to main content

Advertisement

SpringerLink
Log in

Survival After Pelvic Exenteration for Cervical Cancer

  • Original Article
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

Abstract

Background

The purpose of this work was to identify the results of pelvic exenteration for recurrent, persistent or locally advanced cervical cancer in terms of survival performed for 41 patients in Salah Azaiez Institute.

Patients and Methods

We conducted a retrospective unicentric study. The association between PE and OS was estimated using the method of Kaplan–Meier using SPSS ver 24.

Results

Median age at the time of intervention was 53.9 years old. FIGO stage IIB was the most frequent (46.3%). Eighteen patients had pelvic exenteration after neoadjuvant treatment. Resection margins were free of tumor in 83.3% of cases. Twenty-three patients underwent pelvic exenteration for recurrence of cervical cancer treated. The median time of recurrence was 23.4 months. Free resection margins were obtained in 69.5% of cases. Postoperative complications were noted in 61% of patients. Two deaths were seen in the early postoperative period. After a median follow-up of 40.5 months, 24.4% of recurrences were noted. Overall survival at 5 years was 51% and recurrence-free survival at one year was 39%. Prognostic factors which impact overall and recurrence-free survival were the size of recurrence and resection margins after exenteration. The time between the end of initial treatment and recurrence was the only predictive factor of recurrence after pelvic exenteration.

Conclusion

Pelvic exenteration remains a curative treatment of cervical cancer in certain indications despite high morbidity. A rigorous preoperative selection of candidate may reduce the morbidity and improve the survival of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

    Article  Google Scholar 

  2. Rozario SD, da Silva IF, Koifman RJ, et al. Characterization of women with cervical cancer assisted at Inca by histological type. Rev Saúde Pública. 2019;53:88.

    Article  Google Scholar 

  3. Sardain H, Lavoué V, Foucher F, et al. L’exentération pelvienne curative en cas de récurrence d’un cancer du col de l’utérus à l’ère de la radio-chimiothérapie concomitante: revue de la littérature. J Gynécol Obstét Biol Reprod. 2016;45(4):315–29.

    Article  CAS  Google Scholar 

  4. Marnitz S, Köhler C, Müller M, et al. Indications for primary and secondary exenterations in patients with cervical cancer. Gynecol Oncol. 2006;103(3):1023–30.

    Article  Google Scholar 

  5. Brunschwig A. Complete excision of pelvic viscera for advanced carcinoma. A one-stage abdominoperineal operation with end colostomy and bilateral ureteral implantation into the colon above the colostomy. Cancer. 1948;1(2):177–83.

    Article  CAS  Google Scholar 

  6. Ferron G, Pomel C, Martinez A, et al. Exentération pelvienne: actualités et perspectives. Gynécol Obstét Fertil. 2012;40(1):43–7.

    Article  CAS  Google Scholar 

  7. Benn T, Brooks RA, Zhang Q, et al. Pelvic exenteration in gynecologic oncology: a single institution study over 20 years. Gynecol Oncol. 2011;122(1):14–8.

    Article  CAS  Google Scholar 

  8. Unger JB, Ivy JJ, Connor P, et al. Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women. Gynecol Oncol. 2004;94(1):212–6.

    Article  Google Scholar 

  9. Höckel M. Laterally extended endopelvic resection. Gynecol Oncol. 2003;91(2):369–77.

    Article  Google Scholar 

  10. LaPolla JP, Schlaerth JB, Gaddis O, et al. The influence of surgical staging on the evaluation and treatment of patients with cervical carcinoma. Gynecol Oncol. 1986;24(2):194–206.

    Article  CAS  Google Scholar 

  11. Golda T, Biondo S, Kreisler E, et al. Follow-up of double-barreled wet colostomy after pelvic exenteration at a single institution. Dis Colon Rectum. 2010;53(5):822–9.

    Article  Google Scholar 

  12. Schmidt A-M, Imesch P, Fink D, et al. Indications and long-term clinical outcomes in 282 patients with pelvic exenteration for advanced or recurrent cervical cancer. Gynecol Oncol. 2012;125(3):604–9.

    Article  Google Scholar 

  13. Smith B, Jones EL, Kitano M, et al. Influence of tumor size on outcomes following pelvic exenteration. Gynecol Oncol. 2017;147(2):345–50.

    Article  CAS  Google Scholar 

  14. Westin SN, Rallapalli V, Fellman B, et al. Overall survival after pelvic exenteration for gynecologic malignancy. Gynecol Oncol. 2014;134(3):546–51.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, Salah Azaiez Institute, Tunis, Tunisia

    Imen Bouraoui Resident, Hanen Bouaziz MD, Nesrine Tounsi Surgery oncologist, Racha Ben Romdhane Resident, Monia Hechiche Professor, Maher Slimane Asst.Professor & Khaled Rahal Professor

Authors
  1. Imen Bouraoui Resident
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hanen Bouaziz MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nesrine Tounsi Surgery oncologist
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Racha Ben Romdhane Resident
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Monia Hechiche Professor
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Maher Slimane Asst.Professor
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Khaled Rahal Professor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Imen Bouraoui Resident.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Hanene bouaziz is MD, Department of Surgical Oncology, Salah Azaiez Institute, Tunis, Tunisia; Nesrine Tounsi is a Surgery Oncologist, Department of Surgical Oncology, Salah Azaiez Institute, Tunis, Tunisia; Racha Ben Romdhane is a Resident, Department of Surgical Oncology, Salah Azaiez Institute, Tunis, Tunisia; Monia Hechiche is a Professor, Department of Surgical Oncology, Salah Azaiez Institute, Tunis, Tunisia; Maher Slimane is a Asst. Professor, Department of Surgical Oncology, Salah Azaiez Institute, Tunis, Tunisia; Khaled Rahal is a Professor, Department of Surgical Oncology, Salah Azaiez Institute, Tunis, Tunisia.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bouraoui, I., Bouaziz, H., Tounsi, N. et al. Survival After Pelvic Exenteration for Cervical Cancer. J Obstet Gynecol India 72, 66–71 (2022). https://doi.org/10.1007/s13224-021-01502-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-021-01502-0

Keywords

Search

Navigation